Nuvation Bio Inc. (NUVB) stock
NUVBNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30105% above fair value
$3.99−0.07 (-1.72%)
Close on Nov 13, 2026Market cap $1.40BP/E –Yield –
Nuvation Bio statistics
74 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Mar 1, 2027 (estimated, during market hours)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 6.73
- 2.22
Enterprise valuationIndustry
- EV / Sales
- 3.69
- 2.57
Share statisticsIndustry
- Shares Change (YoY)
- 4.66%
- 10.8%
- Shares Change (QoQ)
- 0.00%
- 0.50%
- Float
- 265M
- 49M
- Shares Held by Insiders
- 24.6%
- 11.7%
- Shares Held by Institutions
- 66.5%
- 56.4%
Short sellingIndustry
- Short Interest
- 62M
- –
- Short Interest Change
- -1.93%
- -0.80%
- Short % of Float
- 23.4%
- 9.01%
- Short % of Shares Outstanding
- 17.7%
- 6.30%
- Days to Cover
- 12.50
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $9.75
- –
- 52-Week Low
- $3.94
- –
- 20-Day Moving Average
- $4.49
- –
- 50-Day Moving Average
- $5.13
- –
- 200-Day Moving Average
- $5.33
- –
- Average True Range (14)
- $0.27
- –
- Price Change (1 Week)
- -4.09%
- -1.15%
- Price Change (1 Month)
- -16.0%
- -4.87%
- Price Change (3 Months)
- -38.4%
- -21.0%
- Price Change (6 Months)
- -7.64%
- -20.6%
- Price Change (YTD)
- -55.5%
- -23.6%
- Price Change (1 Year)
- -19.1%
- -22.4%
- Price Change (3 Years)
- 195.6%
- -29.5%
- Price Change (5 Years)
- -57.6%
- -77.9%
- Average Volume (10 Days)
- 5M
- –
- Average Volume (20 Days)
- 5M
- –
- Average Volume (90 Days)
- 5M
- –
- Relative Volume
- 0.56
- 0.70
- Relative Strength Index (14)
- 32.3
- 43.4
- Volatility (1 Year)
- 82.3%
- 80.1%
- Beta (5 Years)
- 1.44
- 1.07
MarginsIndustry
- Pretax Margin
- -67.4%
- -11.6%
- EBITDA Margin
- -60.1%
- -27.7%
Returns on capitalIndustry
- Return on Equity (ROE)
- -49.1%
- -49.9%
- Return on Assets (ROA)
- -19.7%
- -40.6%
- Return on Capital Employed (ROCE)
- -18.2%
- -37.9%
Financial positionIndustry
- Current Ratio
- 7.45
- 3.30
- Quick Ratio
- 7.10
- 2.39
- Debt / Equity
- 0.03
- 0.49
- Interest Coverage
- -5.87
- -6.35
GrowthIndustry
- Revenue Growth (YoY)
- 654.2%
- 6.82%
EfficiencyIndustry
- Asset Turnover
- 0.29
- 0.40
- Revenue Per Employee
- $676.95K
- $429.29K
- Profits Per Employee
- -$456.15K
- -$689.41K
- Employee Count
- 298
- 74
- WACC
- 12.3%
- 10.2%
Income statement (TTM)Industry
- Pretax Income
- -$135.93M
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- $657.40M
- $17.76M
- Net Cash Per Share
- $1.87
- $0.80
- Equity (Book Value)
- $227.98M
- $53.89M
- Book Value Per Share
- $0.65
- $1.50
- Tangible Book Value
- $208.18M
- $27.13M
- Working Capital
- $636.10M
- $79.99M
Cash flow (TTM)Industry
Dividends and yieldsIndustry
- Earnings Yield
- -9.70%
- -21.8%
Taxes and interestIndustry
- Interest Expense
- $21.02M
- $2.90M
- Income Tax
- $0
- $73.00K
Scores and fair valueIndustry
- Altman Z-Score
- 0.06
- 0.23
- Piotroski F-Score
- 4
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | NUVB | S&P 500 | Difference | NUVB per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -15.5% | -3.0% | −12.4 pts | ||
| 3 months | -34.6% | -2.8% | −31.8 pts | ||
| Year to date | -55.5% | +11.5% | −67.0 pts | ||
| 1 year | -14.9% | +13.5% | −28.4 pts | ||
| 3 years | +211.7% | +77.7% | +134.0 pts | +46.1% | +21.1% |
| 5 years | -57.6% | +72.6% | −130.2 pts | -15.8% | +11.5% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
62M NUVB shares were sold short on Oct 30, 2026, down 1.9% from the previous report, or 23.43% of the shares available to trade. At recent volumes it would take 12.5 days to buy them back. Over the last 20 sessions, 55.7% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 61,999,741 | -1.9% | 4,958,594 | 12.5 |
| Oct 15, 2026 | 63,220,203 | +7.4% | 6,546,616 | 9.7 |
| Sep 30, 2026 | 58,862,812 | +1.2% | 4,240,489 | 13.9 |
| Sep 15, 2026 | 58,173,586 | +7.2% | 5,340,743 | 10.9 |
| Aug 31, 2026 | 54,264,998 | +2.0% | 5,087,630 | 10.7 |
| Aug 14, 2026 | 53,222,212 | -0.4% | 6,000,448 | 8.9 |
| Jul 31, 2026 | 53,423,972 | -4.0% | 6,137,601 | 8.7 |
| Jul 15, 2026 | 55,668,014 | +2.4% | 6,930,821 | 8.0 |
| Jun 30, 2026 | 54,363,151 | +11.1% | 11,724,270 | 4.6 |
| Jun 15, 2026 | 48,919,886 | -8.9% | 5,079,494 | 9.6 |
| May 29, 2026 | 53,671,108 | +4.2% | 3,739,786 | 14.3 |
| May 15, 2026 | 51,492,072 | +1.7% | 5,170,907 | 10.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?